| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 02/24/1993 | EP0528583A1 Isolation and structure of the cell growth inhibitory cycloheptapeptide axinastatin 1 |
| 02/24/1993 | EP0528500A2 A method for reduction of central nervous system (CNS) edema resulting from head and spinal cord trauma |
| 02/24/1993 | EP0528487A2 Novel chromophore containing compounds |
| 02/24/1993 | EP0528360A2 Transgenic rats having at least one human gene in their genome, participating in the regulation of the blood-pressure |
| 02/24/1993 | EP0528312A2 Cyclic peptides and use thereof |
| 02/24/1993 | EP0527789A1 Hiv envelope polypeptides |
| 02/24/1993 | EP0527778A1 Improved process of purifying recombinant proteins and compounds useful in such process. |
| 02/24/1993 | EP0510132A4 Polymeric carriers for release of covalently linked agents |
| 02/23/1993 | US5189144 Human calpastatin-like polypeptide |
| 02/23/1993 | US5189022 Using polypeptide |
| 02/23/1993 | US5189021 Administering LH-RH analog peptide |
| 02/23/1993 | US5189018 Method for reduction of central nervous system (cns) edema resulting from head and spinal cord trauma |
| 02/23/1993 | CA2076558A1 Pharmaceutical compositions containing bradykinin antagonists for local use on the nose and eyes |
| 02/20/1993 | CA2076321A1 Method for reduction of central nervous system (cns) edema resulting from head and spinal cord trauma |
| 02/18/1993 | WO1993003146A1 Disease associated b-cell epitopes of tpo and use thereof |
| 02/18/1993 | WO1993003059A1 Cyclic hexapeptides as tachyquinin antagonists, their preparation and pharmaceutical compositions thereof |
| 02/18/1993 | WO1993003058A2 NON-DESENSITIZING ANALOGS OF GnRH AND OTHER BIOLOGICALLY ACTIVE LIGANDS |
| 02/18/1993 | WO1993003057A1 Polypeptides capable of in vivo induction of antibodies themselves capable of inhibiting the invasion of red blood corpuscles by merozoites of p.falciparum, related products and their use in producing vaccine compositions |
| 02/18/1993 | WO1993003056A1 Lanthionine bridged peptides |
| 02/18/1993 | WO1993003055A1 Peptide compounds inhibiting hiv adsorption on target cells |
| 02/18/1993 | WO1993003054A1 Novel tetrapeptide derivative |
| 02/18/1993 | WO1993002708A1 Novel reagent for tumour imaging and therapy |
| 02/18/1993 | CA2115246A1 Lanthionine bridged peptides |
| 02/18/1993 | CA2114223A1 Polypeptides capable of in vivo induction of antibodies themselves capable of inhibiting the invasion of red blood corpuscles by merozoites of p. falciparum, related products and their use in producing vaccine compositions |
| 02/18/1993 | CA2113280A1 Disease associated b-cell epitopes of tpo and use thereof |
| 02/18/1993 | CA2112566A1 Non-desensitizing analogs of gnrh and other biologically active ligands |
| 02/17/1993 | CA2075685A1 Chromophore containing compounds and their use in determining interleukin-1b convertase activity |
| 02/17/1993 | CA2075662A1 Chromophore containing compounds and their use in determining interleukin-1b convertase activity |
| 02/15/1993 | CA2076194A1 Transgenic rats containing in their genome at least one human gene which participates in blood pressure control |
| 02/10/1993 | EP0527056A1 Novel reagent for tumour imaging and therapy |
| 02/10/1993 | EP0402415B1 Synthetic scm-active cancer recognition peptides |
| 02/09/1993 | WO1993002697A1 Production of peptide amides |
| 02/09/1993 | US5185319 Administering a mixture of insulin and a 30hydroxypyrid-4-one |
| 02/09/1993 | US5185266 Cleaving an alkylated thiohydantoin adduct from a peptide under anhydrous, acidic conditions and analyzing the side chain of the amino acid |
| 02/09/1993 | CA2115159A1 Production of peptide amides |
| 02/09/1993 | CA2074700A1 Isolation and structure of the cell growth inhibitory cycloheptapeptide axinastatin 1 |
| 02/04/1993 | WO1993002192A1 Modified pf4 compositions and methods of use |
| 02/04/1993 | WO1993001828A1 Lipid conjugates of therapeutic peptides and protease inhibitors |
| 02/04/1993 | WO1993001827A1 Osteoclast growth regulatory factor |
| 02/04/1993 | WO1993001802A1 Composition for the sustained and controlled release of a medicinal peptide-containing substance, and preparation method therefor |
| 02/04/1993 | WO1993001723A1 Prophylaxis and treatment of adverse oral conditions with biologically active peptides |
| 02/04/1993 | WO1992022332A3 Drug delivery of antisense oligonucleotides and peptides to tissues in vivo and to cells using avidin-biotin technology |
| 02/04/1993 | CA2113828A1 Osteoclast growth regulatory factor |
| 02/04/1993 | CA2113206A1 Modified pf4 compositions and methods of use |
| 02/04/1993 | CA2113156A1 Lipid conjugates of therapeutic peptides and protease inhibitors |
| 02/03/1993 | EP0526192A2 Hexapeptide |
| 02/03/1993 | EP0525889A1 Process for phosphate ester compounds of certain cyclohexapeptides |
| 02/03/1993 | EP0525838A2 Growth hormone releasing factor analogs |
| 02/03/1993 | EP0349545B1 New cardiodilatin fragment, process for preparing same and use thereof |
| 02/02/1993 | US5183805 Bioactive egf peptides for promotion of tissue regeneration and cancer therapy |
| 02/02/1993 | US5183804 Anticarcinogenic agents |
| 02/02/1993 | US5183734 Antibodies, diagnostic systems and methods for assaying SV40 HBxAg |
| 02/02/1993 | US5183660 Drugs having decreased antigenicity, delayed biological clearance and exhibit physiological activity over a long period |
| 01/31/1993 | CA2074967A1 Hexapeptide |
| 01/31/1993 | CA2074759A1 Process for phosphate ester compounds of certain cyclohexapeptides |
| 01/28/1993 | DE4223282A1 Zubereitung zur stetigen und kontrollierten abgabe von medikamentoesen substanzen und verfahren zu deren herstellung Preparation for continuous and controlled release of medicamentous substances and processes for their preparation |
| 01/27/1993 | EP0524260A1 GPIb$g(a) FRAGMENTS AND RECOMBINANT DNA EXPRESSION VECTORS |
| 01/27/1993 | CN1068334A Peptides useful in regulating immune and nervous systems |
| 01/26/1993 | CA2074626A1 Prophylaxis and treatment of adverse oral conditions with biologically active peptides |
| 01/26/1993 | CA1313157C Gastrin releasing peptide antagonist |
| 01/21/1993 | WO1993001316A1 Differentiation of htlv-i and htlv-ii using synthetic peptides |
| 01/21/1993 | WO1993001291A1 Herpes virus proteinase and method of assaying |
| 01/21/1993 | WO1993001215A1 Pla2 inhibitory compounds |
| 01/21/1993 | WO1993001211A1 Peptide which abrogates tnf and/or lps toxicity |
| 01/21/1993 | WO1993001206A1 Conformationally restricted biologically active peptides, methods for their production and uses thereof |
| 01/21/1993 | CA2112255A1 Herpes virus proteinase and method of assaying |
| 01/20/1993 | EP0523675A1 Inhibitory agent against HIV superinfection |
| 01/20/1993 | EP0523395A2 Seroreactive domains from the HPV 16 E1 and E2 proteins |
| 01/20/1993 | EP0379511B1 Polypeptides with laminin activity |
| 01/19/1993 | USRE34165 Pentapeptide immunoregulators |
| 01/19/1993 | US5180806 Polypeptides and compositions of human papillomavirus latent proteins, diagnostic systems and methods |
| 01/19/1993 | US5180712 Alzheimer's disease |
| 01/19/1993 | US5180711 Combined treatment with gnrh antagonist and gnrh to control gonadotropin levels in mammals |
| 01/13/1993 | EP0522482A2 Coccidiosis vaccines |
| 01/13/1993 | EP0522152A1 Lhrh antagonists |
| 01/13/1993 | EP0522091A1 Multiple sclerosis t-cell receptor |
| 01/13/1993 | EP0522081A1 Inhibition of disease associated with immunodeficiency virus infection |
| 01/13/1993 | EP0216833B1 Novel insulin derivatives and pharmaceutical preparations containing these derivatives |
| 01/13/1993 | CA2073588A1 Coccidiosis vaccines |
| 01/09/1993 | CA2046484A1 Peptides |
| 01/07/1993 | WO1993000365A2 Hepatitis c virus (hcv) polypeptides |
| 01/07/1993 | WO1993000359A1 Modified peptides transportable into the central nervous system |
| 01/07/1993 | WO1993000108A1 Novel inhibitors of platelet aggregation |
| 01/07/1993 | WO1993000105A1 Calpain-inhibiting peptide analogs of the kininogen heavy chain |
| 01/07/1993 | EP0521408A1 Glycopeptide antibiotics derivated from balhimycin |
| 01/07/1993 | DE4209215A1 Hcv peptidantigene und verfahren zur bestimmung von hcv HCV peptide antigens, and methods for the determination of HCV |
| 01/07/1993 | DE4121662A1 New balhimycin derivs. obtd. from Actinomyces Y-86,21022 |
| 01/07/1993 | CA2111870A1 Calpain-inhibiting peptide analogs of the kininogen heavy chain |
| 01/05/1993 | WO1993001210A2 Hcv peptide-antigens and a method of testing for the hepatitis c virus (hcv) |
| 01/05/1993 | US5177060 Anti-inflammatory peptides and treatment to inhibit vascular leakage in injured tissues |
| 01/05/1993 | US5177024 Determining cereal quality |
| 01/05/1993 | CA2089576A1 Hcv peptide antigens and methods for the determination of hcv |
| 01/04/1993 | CA2046124A1 Cyclic peptides |
| 12/30/1992 | EP0519986A1 Synthetic polypeptides |
| 12/30/1992 | CA2072725A1 Glycopeptides, a process for their preparation and their use |
| 12/29/1992 | US5175253 Serpin-enzyme complex receptor binding pentapetides |
| 12/29/1992 | US5175146 Synthetic calcitonin peptides |
| 12/23/1992 | WO1992022656A1 Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis |
| 12/23/1992 | WO1992022575A1 M-protein peptides of influenza virus as antiviral agents |
| 12/23/1992 | WO1992022573A1 Detection of mammalian immunodeficiency viruses |